Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06878716

Silver Russell Syndrome, Parental Fertility and Assisted Reproductive Technology

Silver Russell Syndrome (SRS) is a rare imprinting disorder (about 1/16000). Parental imprinting is an epigenetic regulation phenomenon leading to the monoallelic expression of some genes. Its establishment takes place in the gametes and its maintenance is important at the early embryonic stage. Increase in the prevalence of conception by assisted reproductive technology (ART) has already been found in patients with imprinted disorder such as Angelman, Beckwith-Wiedemann or Prader Willi Syndromes, and more recently with SRS; ART is associated with an increase in the frequency of SRS. Several hypotheses are formulated to explain this increase. The first one is the involvement of the infertility etiology in the imprinting disorder genesis. The second one is the involvement of ART technics in the genesis of abnormal gamete imprinting during their manipulation or during imprinting maintenance at early embryonic stages.

Our main objective is to estimate ART conceptions prevalence in children followed for a SRS. The secondary objectives are to estimate infertility prevalence among parents of patients with SRS, to estimate factors frequency possibly responsible for the genesis of imprinting anomalies among parents of patients with SRS, to describe the infertility causes and to detail ART technics used (stimulation protocols, type of fertilization used, modality of embryonic culture and transfer, embryonic characteristics).

A transversal pilote study will be firstly conducted in parents of patients followed in Silver Russell Syndrome Reference Center (Pediatric Endocrine department, in Trousseau Hospital, Paris).

Data collection will be done by phone, after collecting the non-opposition of the parents, in order to complete a questionnaire concerning their fertility and conception mode of their child. If ART was used to conceive, a questionnaire concerning the details of the ART technics used will be sent to the doctor and:or the ART biologist, who performed the ART. The data will be anonymized and collected on a REDCap database.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

There is no planned follow-up, and the parents' participation is limited to the telephone interview.

The aim is to conduct / carry out a single-centre observational cross-sectional study, on the one hand by collecting data from the centre's patient files (molecular anomaly leading to the diagnosis of Silver Russell syndrome) and on the other hand by conducting a 30-minute telephone questionnaire to collect additional data. The first part of this questionnaire will be carried out with the parents of these patients in order to specify their age, height, weight, drug consumption and profession at the time of the start of pregnancy, as well as the time required for conception and recourse to ART.

In the event of recourse to ART, with the authorisation of the parent(s), a questionnaire will be sent to the clinical doctor and/or the biologist at the ART centre.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥ 18 years old
  • parents from patients followed in the department " Unité Fonctionnelle Endocrinienne du Pr Netchine " for un Silver Russell syndrome

Exclusion criteria

  • parent's objection
  • patient under State Medical Aid

Treatment and study plan

Primary outcomes

  1. Proportion of SRS patients whose mode of conception was ART

    Time frame: Day 0, visit inclusion

    To estimate ART conceptions prevalence in children followed for a SRS

Secondary outcomes

  1. Estimate infertility prevalence among parents of patients with SRS (defined as a delay to conception of more than 12 months)

    Time frame: Day 0, visit inclusion

    The time required for conception is defined by the time between stopping contraception and the start of pregnancy

  2. Estimate frequency of maternal and paternal BMI at the time of conception

    Time frame: Day 0, visit inclusion

  3. Estimate frequency of consumption of tobacco and alcohol at the time of conception

    Time frame: Day 0, visit inclusion

    At the time of conception maternal and paternal BMI, consumption of tobacco and alcohol and both parents' occupations

  4. Estimate frequency of parents's profession at the time of conception

    Time frame: Day 0, visit inclusion

  5. The etiology of infertility in detail

    Time frame: 3 years, end of the study

    Study infertility causes in detail this will be do through a questionnaire send to the fertility doctor who treated the parents.

  6. Describe the ART techniques used from the point of view of ovarian stimulation but also oocyte, sperm and embryo manipulations

    Time frame: 3 years, end of the study

    Details of ART techniques used this will be do through a questionnaire send to the fertility doctor who treated the parents.

Study contacts

Contact information is provided by the study sponsor or research team.

Irène Netchine, PUPH, MD, PhD

CONTACT

[email protected]

0033 1 44 73 66 31

Marie-Pierre Luton, PhD

CONTACT

[email protected]

+33(0) 1 87 89 26 00

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Official study title

Official Title : Silver Russell Syndrome, Parental Fertility and Assisted Reproductive Technology 600 caractères Maximum

Acronym: SRS-AMP

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Mar 17, 2025
Registry last updated
Mar 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.